Abstract: A system for verifying software development compliance includes a processor and memory having instructions stored thereon that, when executed by the processor, cause the system to determine that a user has submitted a change to source code stored in a source code repository and, before merging the change with the source code, to perform a compliance analysis of the source code repository by comparing parameters of the source code repository against a set of compliance rules and block the change from being merged with the source code if it is determined that the source code repository is non-compliant. A report is then generated that includes details of the compliance analysis, wherein the report indicates at least whether the source code repository passed or failed for each rule of the set of compliance rules.

Abstract: Compounds, pharmaceutically acceptable salts, stereoisomers and prodrugs thereof, that are ER ligands and particularly to such compounds that are ER beta-selective and/or ER beta-specific ligands. Compounds herein include certain compounds which are ER beta-selective agonists. Compounds herein include ER beta-selective agonists which exhibit minimal agonist or antagonist effect on ER alpha. Compounds of the invention include those of formula I: and any pharmaceutically acceptable salts, stereoisomers and prodrugs thereof wherein AR, R1, R3, and X1—X4 are as defined hereinabove.